(redirected from growth hormone receptor antagonist)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
References in periodicals archive ?
As Executive Vice President of Sensus, a biotech company founded in Austin and subsequently acquired by Pharmacia (Pfizer), Davis was instrumental in the successful registration of Somavert(R), a growth hormone receptor antagonist, in the US, Europe and Japan.
That market is currently dominated by once-a-month Sandostatin LAR(R) Depot (octreotide acetate for injectable suspension) from Novartis (NYSE: NVS) and includes daily injections of Somavert (pegvisomant for injection), a growth hormone receptor antagonist, from Pfizer (NYSE: PFE).
Shearwater") today announced a license agreement with Sensus Drug Development Corporation ("Sensus") for the PEGylation of Sensus' Somavert(TM) (pegvisomant for injection) human growth hormone receptor antagonist using Shearwater's proprietary technology.

Full browser ?